The role of virulence factors in the outcome of staphylococcal peritonitis in CAPD patients

BMC Infectious Diseases

Volumn 9, Issue , 2009, Pages

  Barretti, Pasqual ^a   Montelli, Augusto C ^a   Batalha, Jackson E N ^a   Caramori, Jacqueline C T ^a   Cunha, Maria D L R ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA HEMOLYSIN; AMIKACIN; CEFAZOLIN; ENTEROTOXIN; HEMOLYSIN; NUCLEASE; OXACILLIN; PHOSPHOLIPASE; TOXIC SHOCK SYNDROME TOXIN 1; TRIACYLGLYCEROL LIPASE; VANCOMYCIN; VIRULENCE FACTOR; COAGULASE;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL PERITONITIS; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DRUG WITHDRAWAL; EPSILOMETER TEST; FEMALE; HUMAN; LOADING DRUG DOSE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; OUTCOME ASSESSMENT; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TREATMENT FAILURE; UNIVERSITY HOSPITAL; BIOSYNTHESIS; COMPARATIVE STUDY; METABOLISM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; MORTALITY; MULTIDRUG RESISTANCE; PATHOGENICITY; PERITONITIS; STAPHYLOCOCCUS INFECTION; STATISTICAL MODEL; TREATMENT OUTCOME;

ADULT; COAGULASE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONITIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TREATMENT OUTCOME; VIRULENCE FACTORS; YOUNG ADULT;

EID: 74549132203     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-9-212     Document Type: Article

References (31)

1. Davenport A. Peritonitis remains the major clinical complication of peritoneal dialysis: The London, UK, Peritonitis Audit 2002-2003. Perit Dial Int 2009, 29:297-302.
2. Perez Fontan M, Rodriguez-Carmona A, Garcia-Naveiro R, Rosales M, Villaverde P, Valdes F. Peritonitis-related mortality in patients undergoing chronic peritoneal dialysis. Perit Dial Int 2005, 25:274-84.
3. Troidle LK, Finkelstein FO. Treatment and outcome of CPD-associated peritonitis. Ann Clin Microbiol Antimicrob 2006, 5:6-25. 10.1186/1476-0711-5-6, 1456984, 16600033.
4. Troidle L, Gorban-Brennan N, Kliger A, Finkeltein F. Differing outcomes of gram-positive and gram-negative. Am J Kidney Dis 1998, 32:623-628. 10.1016/S0272-6386(98)70026-5, 9774124.
5. Bunke CM, Brier ME, Golper TA. Outcomes of single organism peritonitis in peritoneal dialysis: gram negatives versus gram positives in the Network 9 Peritonitis Study. Kidney Int 1997, 52:524-529. 10.1038/ki.1997.363, 9264012.
6. Peacock SJ, Howe PA, Day NP, Crook DW, Winearls CG, Berendt AR. Outcome following staphylococcal peritonitis. Perit Dial Int 2000, 20:215-219.
7. Krishnan M, Thodis E, Ikonomopoulos D, Vidgen E, Chu M, Bargman JM, Vas SI, Oreopoulos DG. Predictors of outcome following bacterial peritonitis in peritoneal dialysis. Perit Dial Int 2002, 22:573-581.
8. de Lourdes Ribeiro de Souza da Cunha M, Montelli AC, Fioravante AM, Neves Batalha JE, Texeira Caramori JC, Barretti P. Predictive factors of outcome following staphylococcal peritonitis in continuous ambulatory peritoneal dialysis. Clin Nephrol 2005, 64:378-382. 16312266.
9. Kim DK, Yoo TH, Ryu DR, Xu ZG, Kim HJ, Choi KH, Lee HY, Han DS, Kang SW. Changes in causative organisms and their antimicrobial susceptibilities in CAPD peritonitis: a single center's experience over one decade. Perit Dial Int 2004, 24:424-432.
10. Holley JL, Bernadini J, Johnston JR, Piraino B. Methicillin-resistant staphylococcal Infections in an outpatient peritoneal dialysis program. Am J Kidney Dis 1990, 16:142-146.
11. Kristinsson KG, Spencer RC, Hastings JGM, Brown CB. Slime production by coagulase negative Staphylococci - a major virulence factor?. Contr Nephrol 1987, 57:79-84.
12. Vogel L, Sloos JH, Spaargaren J, Suiker I, Dijkshoorn L. Biofilm production by Staphylococcus epidermidis isolates associated with catheter related bacteremia. Diagn Microbiol Infect Dis 2000, 36:139-41. 10.1016/S0732-8893(99)00124-8, 10705058.
13. Kristinsson KG, Spencer RC, Brown CB. Clinical importance of production of slime by coagulase negative staphylococci in chronic ambulatory peritoneal dialysis. J Clin Pathol 1986, 39:117-118. 10.1136/jcp.39.1.117, 499632, 3950026.
14. Alexander W, Rimland D. Lack of correlation of slime production with pathogenicity in continuous ambulatory peritoneal dialysis peritonitis caused by coagulase negative staphylococci. Diagn Microbiol Infect Dis 1987, 8:215-220. 10.1016/0732-8893(87)90052-6, 3449316.
15. de Lourdes Ribeiro de Souza da Cunha M, Caramori JC, Fioravante AM, Batalha JE, Montelli AC, Barretti P. Significance of slime as virulence factor in coagulase-negative staphylococcus peritonitis in CAPD. Perit Dial Int 2004, 24:191-193. 15119642.
16. Dingues MM, Orwin PM, Schlievert M. Exotoxins of Staphylococcus aureus. Clin Microb Reviews 2000, 13:16-34.
17. Keane WF, Alexander SR, Bailie GR, Boeschoten E, Gokal R, Golper TA, Holmes CJ, Huang CC, Kawaguchi Y, Piraino B, Riella M, Schaefer F, Vas S. Peritoneal dialysis-related peritonitis treatment recommendations: 1996 update. Perit Dial Int 1996, 16:557-573.
18. Keane WF, Bailie GR, Boeschoten E, Gokal R, Golper TA, Clifford JH, Kawaguchi Y, Piraino B, Riella M, Vas S. Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update. Perit Dial Int 2000, 20:396-411.
19. Kloos WE, Schleifer KH. Simplified scheme for routine identification of human Staphylococcus species. J Clin Microbiol 1975, 1:82-88. 274946, 170303.
20. Kloos WE, Bannerman TL. Staphylococcus and Micrococcus. Manual of Clinical Microbiology 1995, 282-298. Washington, American Society Microbiology, Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH.
21. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing: CLSI approved standard M100-S15. Wayne PA USA 2005, Clinical and Laboratory Standards Institute.
22. Christensen GD. Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect Immun 1982, 37:318-326. 347529, 6179880.
23. Jessen O, Faber V, Rosendal K, Eriksen KR. Some properties of Staphylococcus aureus, possibly related to pathogenicity. Part 1. A study of 446 strains from different types of human infection. Acta Pathol Microbiol Scand 1959, 47:316-326.
24. Matos JE, Harmon RJ, Langlois BE. Lecithinase reaction of Staphylococcus aureus strains of different origin on Baird-Parker medium. Lett Appl Microbiol 1995, 21:334-335. 10.1111/j.1472-765X.1995.tb01073.x, 7576528.
25. Lachica RUF, Genigeorgis C, Hoeprich PD. Metachromatic agar-diffusion methods for detecting staphylococcal nuclease activity. Appl Microbiol 1971, 21:585-587. 377235, 4930272.
26. Donnelly CB. Serological identification of enterotoxigenic staphylococci from cheese. Appl Microbiol 1967, 15:1382-1387. 547206, 16349749.
27. Shingaki MH, Igarashi H, Fujikawa H, Ushioda H, Terayama T, Sakai S. Study on reversed passive latex agglutination for the detection of staphylococcal enterotoxins A-C. Annu Rep Tokyo Metr Res Lab Publ Hlth 1981, 32:128-131.
28. Gruer LD, Bartlett R, Ayliffe GA. Species identification and antibiotic sensitivity of coagulase-negative staphylococci from CAPD peritonitis. J Antimicrob Chemother 1984, 13:577-583. 10.1093/jac/13.6.577, 6332107.
29. Golper T. Intermittent versus continuous antibiotics for PD-related peritonitis. Perit Dial Int 1997, 17:11-12.
30. Haslinger-Loffler B, Wagner B, Bruck M, Strangfeld K, Grundmeier M, Fischer U, Volker W, Peters G, Schulze-Osthoff K, Sinha B. Staphylococcus aureus induces caspase-independent cell death in human peritoneal mesothelial cells. Kidney Int 2006, 70:1089-1098. 10.1038/sj.ki.5001710, 16871245.
31. Glik A, Douvdevani A. Tlymphocytes: the "cellular" arm of acquired immunity in the peritoneum. Perit Dial Int 2006, 26:438-448.